Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
02:50 | Business services provider TaskUs files for a $100 million IPO | ||
00:50 | Wellness products supplier The Bountiful Company files for a $100 million IPO | ||
Mo | AI drug discovery biotech Recursion Pharmaceuticals sets terms for $306 million IPO | ||
Mo | Shanghai-based SPAC Lakeshore Acquisition I files for a $50 million IPO | ||
Mo | Semiconductor manufacturer SkyWater Technology sets terms for $75 million IPO | ||
Mo | Spatial biology company Akoya Biosciences sets terms for $125 million IPO | ||
Mo | Software maker UiPath sets terms for $990 million IPO | ||
Mo | Cybersecurity training platform KnowBe4 sets terms for $201 million IPO | ||
Mo | Micro-cap online gambling platform Esports Technologies increases deal size by 16% ahead of $11 million IPO | ||
Mo | Digital banking platform Alkami Technology raises range to $26 to $28 ahead of $162 million IPO | ||
Sa | US IPO Weekly Recap: The IPO market cools off in a 2 IPO week | ||
Sa | Healthy lifestyle brand The Honest Company files for a $100 million IPO | ||
Sa | US IPO Week Ahead: Coinbase direct-lists in a 5 IPO week | ||
Fr | UK-based immunotherapy biotech Vaccitech files for a $100 million US IPO | ||
Fr | French vaccine biotech Valneva files for a $100 million US IPO | ||
Fr | SPAC OceanTech Acquisitions I files for a $100 million IPO, targeting the leisure marine industry | ||
Fr | California bank Five Star Bancorp files for a $100 million IPO | ||
Fr | Swiss rare disease biotech VectivBio Holding prices US IPO at $17 midpoint | ||
Fr | SPAC Aldel Financial prices $100 million IPO, led by Fortress co-founder Robert Kauffman | ||
Fr | SPAC TPG Pace Solutions prices $250 million IPO, as TPG targets turnaround stories | ||
Fr | Rare disease biotech Reneo Pharmaceuticals prices IPO at $15, the low end of the range | ||
Fr | Post Holdings' SPAC Post Holdings Partnering lowers deal size by 25% ahead of $300 million IPO | ||
Fr | Smooth sailing: Catamaran boat maker Twin Vee PowerCats files for a $22 million IPO | ||
Fr | Preclinical cancer biotech Werewolf Therapeutics files for a $100 million IPO | ||
Fr | Phase 1 cancer biotech Artiva Biotherapeutics files for a $100 million IPO |